CalcPep Research

Liraglutide

FDA Approved

Also known as: Victoza, Saxenda

Track with CalcPep

What is Liraglutide?

Liraglutide is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes (Victoza) and chronic weight management (Saxenda).

How It Works

Liraglutide mimics GLP-1, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite.

What Research Shows

80
Animal Studies
60
Human Studies

Key Findings:

  • FDA-approved for T2D and obesity
  • 5-10% body weight loss in trials
  • Cardiovascular benefits demonstrated

Dosing Protocol

Typical Dose
0.6-3 mg
Frequency
Once daily
Route
Subcutaneous injection
Duration
Ongoing

These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.

Safety & Risks

Reported Side Effects:

NauseaVomitingDiarrheaConstipationInjection site reactions

Contraindications:

  • Personal/family history of medullary thyroid carcinoma
  • MEN 2 syndrome
  • Pregnancy

Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.

Sourcing & Quality

Quality varies significantly between peptide sources. When sourcing Liraglutide, consider:

  • Third-party testing (HPLC, Mass Spectrometry)
  • Certificate of Analysis (CoA) availability
  • Purity levels (>98% recommended)
  • Beware of LPS (endotoxin) contamination

CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.

Quick Facts
Category
Weight Loss
Status
FDA Approved
Typical Dose
0.6-3 mg
Route
Subcutaneous injection
Duration
Ongoing
Real-World Data
2,876
Users Reporting

Aggregated from CalcPep users who have opted in to share anonymous data.

View Full Data

Track Your Protocol

Use CalcPep to calculate doses, log injections, and track your progress.

Get CalcPep